$DCTH News

Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why

Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy

Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?

Delcath: Temporary Headwinds Are Fading While Larger Opportunities Approach

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $32

Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call Transcript

Delcath Systems Q2 Earnings Call Highlights

BTIG Maintains Buy on Delcath Systems, Raises Price Target to $21

Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

Delcath Systems Q2 EPS $0.07 Beats $(0.09) Estimate, Sales $29.133M Beat $26.259M Estimate

Delcath Systems Sees FY2026 Sales $104.000M-$108.000M vs $103.242M Est

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

Delcath Systems to Host Second Quarter 2026 Earnings Call

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference

Delcath (DCTH) Q1 2026 Earnings Transcript